000824184 000__ 03342cam\a2200493Ii\4500
000824184 001__ 824184
000824184 005__ 20230306144108.0
000824184 006__ m\\\\\o\\d\\\\\\\\
000824184 007__ cr\cn\nnnunnun
000824184 008__ 171026s2018\\\\si\\\\\\ob\\\\000\0\eng\d
000824184 019__ $$a1013519205
000824184 020__ $$a9789811044663$$q(electronic book)
000824184 020__ $$a981104466X$$q(electronic book)
000824184 020__ $$z9789811044656
000824184 0247_ $$a10.1007/978-981-10-4466-3$$2doi
000824184 035__ $$aSP(OCoLC)on1007699338
000824184 035__ $$aSP(OCoLC)1007699338$$z(OCoLC)1013519205
000824184 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dGW5XE$$dN$T$$dAZU$$dMERER$$dOCLCF$$dCOO$$dUAB$$dOCLCQ$$dU3W$$dCAUOI
000824184 049__ $$aISEA
000824184 050_4 $$aRD539
000824184 08204 $$a616.2/4$$223
000824184 24500 $$aDrug-induced lung injury /$$cMasayuki Hanaoka, Hiroyuki Nakamura, Kazutetsu Aoshiba, editors.
000824184 264_1 $$aSingapore :$$bSpringer,$$c[2018]
000824184 300__ $$a1 online resource.
000824184 336__ $$atext$$btxt$$2rdacontent
000824184 337__ $$acomputer$$bc$$2rdamedia
000824184 338__ $$aonline resource$$bcr$$2rdacarrier
000824184 347__ $$atext file$$bPDF$$2rda
000824184 4901_ $$aRespiratory disease series: Diagnostic tools and disease managements,$$x2509-5552
000824184 504__ $$aIncludes bibliographical references.
000824184 5050_ $$aPart I Definition, Pathogenesis, and Epidemiology -- 1. Definition, Pathogenesis and Epidemiology: What is DLI-- 2. Epidemiology and Risk Factors of Drug-Induced Lung Disease: What are the prevalence and risk factors of DLI-- 3. Clinical Characteristics of DLI: What are the clinical features of DLI-- Part II Diagnosis -- 4. Diagnostic Approach for DLI: How is DLI diagnosed-- 5. Blood tests for the diagnosis and/or management of DLI: What are the clinical significances of KL-6, SP-A, SP-D and DLST in DLI-- 6. Imaging features of drug-induced interstitial lung disease: How HRCT of DLI is interpreted-- 7. Pathology of DLI: What is the pathological significance of DLI-- 8. Differential Diagnosis of DLI: What are the differential diagnoses of DLI-- Part II Treatment -- 9. Therapeutic Strategies for DLI: How should DLI be treated-- Part IV Drugs Causing DLI -- 10. DLI induced by non-molecular target antineoplastic drugs: What are the characteristics of DLI in non-molecular target antineoplastic drugs-- 11. DLI induced by Molecular Target Antineoplastic Drug: What are the characteristics of DLI in molecular target antineo-plastic drugs-- 12. DLI caused by disease-modifying antirheumatic drugs: What are the characteristics of DLI by disease-modifying antirheumatic drugs-- 13. DLI Induced by Herbal Medicine: What are the characteristics of DLI due to herbal medicines-- 14. DLI induced by Antiarrhythmic Drug and Antimicrobial Drug: What are the characteristics of DLI in antiarrhythmic drugs and antimicrobial drugs.
000824184 506__ $$aAccess limited to authorized users.
000824184 588__ $$aOnline resource; title from PDF title page (viewed October 30, 2017).
000824184 650_0 $$aLungs$$xWounds and injuries.
000824184 650_0 $$aDrugs$$xSide effects.
000824184 7001_ $$aHanaoka, Masayuki,$$eeditor.
000824184 7001_ $$aNakamura, Hiroyuki,$$eeditor.
000824184 7001_ $$aAoshiba, Kazutetsu,$$eeditor.
000824184 77608 $$iPrint version: $$z9789811044656
000824184 830_0 $$aRespiratory disease series.
000824184 852__ $$bebk
000824184 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-981-10-4466-3$$zOnline Access$$91397441.1
000824184 909CO $$ooai:library.usi.edu:824184$$pGLOBAL_SET
000824184 980__ $$aEBOOK
000824184 980__ $$aBIB
000824184 982__ $$aEbook
000824184 983__ $$aOnline
000824184 994__ $$a92$$bISE